Aurora Cannabis Inc.
Every calculator, already run for ACB
Open the full toolkit →You have the numbers on ACB. Get the argument.
A written report on which of these readings actually decide the outcome for Aurora Cannabis Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
6 analysts covering ACBOwnership & short interest
About Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedRelea…
ACB — frequently asked
Is ACB a buy right now?
Wall Street's consensus rating on Aurora Cannabis Inc. is Buy across 6 analysts. Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
When is ACB's next earnings date?
Aurora Cannabis Inc. is next scheduled to report earnings around Nov 4, 2026. A full ACB research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
Compare Aurora Cannabis Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Aurora Cannabis Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full ACB research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Aurora Cannabis Inc., in minutes. 3 free reports included with every account — no credit card required.